I always find it interesting when a study comes out saying that there isn't a real difference between tight regulation (though pharmacological means) and improved long-term outcomes of the disease the tighter control is meant to help.
This study is a case in point. It looks at the incidence of adverse cardiovascular outcomes during the follow up period. It determines that those with BP kept under 130 mm Hg systolic pressure did not decrease their chances of dying in the follow-up period more than those with a BP kept between the 140-130 mm Hg level.
Usually, the extra control comes from adding another BP medication. But my question has always been, is that extra med doing any good? And, is that extra med doing more harm, since it is another non-food item the body has to metabolize and get out of the system.
I am not advocating you go off your BP meds right now -- but I think it at least bears some thought and perhaps some thoughtful discussion with your health care provider. Like so many other things -- sometimes more is not better...it is just more.
No comments:
Post a Comment